Quit Genius is pioneering digital therapeutics for multiple addictions.
Quit Genius has raised €64M across 2 funding rounds from 5 investors, most recently a Series B round in Jul 2021. Based in London, UK; founded 2017; active in Healthtech. Data as of 7 Aug 2026.
Timing: dormant vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors |
|---|
| 2021-07-21 | Series B | €54M | Atomico,Kinnevik,Octopus Ventures,Startup Health,Triple Point Ventures | View deal → |
| 2020-03-18 | Series A | €10M | Octopus Ventures | View deal → |
